Jim Mazzola | Senior Vice President, Communication and Investor Relations |
Athena Countouriotis | President and Chief Executive Officer |
Paolo Tombesi | Executive Vice President and Chief Financial Officer |
Mohammad Hirmand | Executive Vice President and Chief Medical Officer |
Paul Choi | Goldman Sachs |
Michael Schmidt | Guggenheim Securities |
Matt Biegler | Oppenheimer |
David Nierengarten | Wedbush Securities |
Andrew Berens | SVB Leerink |
Zegbeh Jallah | ROTH Capital Partners |
Silvan Turkcan | JMP Securities |
Arlinda Lee | Canaccord Genuity |
Thank you all for standing by, and welcome to the Turning Point Therapeutics Second Quarter 2021 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Jim Mazzola, Head of Investor Relations.